15 February 2010

Long-acting CAB/RPV in people with suboptimal adherence: IMPALA study results at 48 weeks 17 July 2025
Potential for once-monthly oral PrEP using MK-8527 17 July 2025
Five doses a week could be a safe option for adults: crisis response to ART stock-outs 16 July 2025
5-on 2-off dosing is inferior to continuous ART in BREATHER Plus – but no difference in clinical outcomes 16 July 2025
All early access reports

Current issues

July 2025
June 2025
May 2025
Back issues

Special report

AIDS quilts at the Tate: reflection and also anger 8 July 2025

More from HTB

Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage

Home

i-Base homepage
Donate

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
Registered charity number: 1081905. Company number: 3962064.

Search i-Base

Site navigation

Quick links: HIV positive; Donate; Feedback

Advice and information: Q and A; Guides; HIV meds; Glossary

Research reports: HTB; HTB South; Pipeline report

Publications and resources: Publications; Other resources; Translations; Slide sets; Order and subscribe

Advocates' network: UK-CAB; Training manual

i-Base: About us; Contact; News and updates; Sitemap; Home

Find us on Facebook

15 February 2010

Contents

Side effects